Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Monopar Therapeutics from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Monopar Therapeutics quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
Monopar Therapeutics Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2025 was $8,564.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$8,564			30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$10,350			30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q4 2023	$68	-$2,274	-97%	31 Dec 2023	10-K	28 Mar 2024	2023	FY
Q4 2022	$2,342			31 Dec 2022	10-K	23 Mar 2023	2022	FY
Q3 2022	$3,395			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$4,635			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$3,402			31 Mar 2022	10-Q	12 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.